HSCA Statement on Recent Executive Order to Promote Domestic Production of Critical Medicines
Washington, DC (May 20, 2025) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), today released the following statement from President and CEO Angie Boliver regarding the recent Executive Order on Regulatory Relief to Promote Domestic Production of Critical Medicines:
“HSCA and its traditional healthcare group purchasing organization (GPO) members applaud the Trump Administration’s recent Executive Order on Regulatory Relief to Promote Domestic Production of Critical Medicines. HSCA has long advocated for policymakers to encourage investments in manufacturing capacity and quality, which are of critical importance for hospitals and the patients they serve. We support the Administration’s efforts to align foreign manufacturing facility inspections with those conducted domestically, including by increasing the fees for and number of inspections. Moreover, HSCA supports the order’s provisions focused on streamlining the permitting and construction of domestic manufacturing facilities. Expediting the building process for pharmaceutical manufacturing sites will help suppliers scale up domestic production quickly. We hope to continue working with the Administration on its domestic production objectives moving forward.”
Click here to view the full statement.
Lear MoreHSCA Response to the U.S. Department of Commerce’s Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading traditional healthcare group purchasing organizations (GPOs), we appreciate the opportunity to provide comments to the U.S. Department of Commerce on its Section 232 national security investigation into pharmaceutical imports.
Click here to view the full response.
Lear MoreHSCA Response to the U.S. Trade Representative’s Request for Comments on Unfair and Non-Reciprocal Foreign Trade Practices
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading traditional healthcare group purchasing organizations (GPOs), we appreciate the opportunity to provide comments to the U.S. Trade Representative (USTR) on ways to strengthen U.S. trade policy and domestic production.
Click here to view the full response.
Lear MoreWhat They’re Saying – Hospitals, Healthcare Organizations, and Patients Supporting the Work of GPOs to Prevent and Mitigate Drug Shortages
Recently, leading healthcare organizations, hospitals, providers, and individuals have made their voices heard on the role traditional healthcare group purchasing organizations (GPOs) play in helping to mitigate and prevent ongoing drug shortages across the country.
Click here to read the full one-pager.
Lear MoreHSCA NAMES ANGIE BOLIVER AS PRESIDENT AND CEO
Washington, D.C. (June 10, 2024) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), today announced that it has named GPO industry expert and public affairs veteran Angie Boliver as President and Chief Executive Officer (CEO). The announcement follows the retirement of former President and CEO Todd Ebert, who led HSCA for seven years.
Click here to read the full press release.
Lear MoreHSCA Comments on Federal Trade Commission (FTC) and Department of Health and Human Services (HHS) Joint RFI on Generic Drug Shortages
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading traditional healthcare group purchasing organizations (GPOs), we appreciate the opportunity to provide our response to the joint RFI published by the FTC and HHS on February 15, 2024.
Click here to read the full response.
Lear More